李嘉诚及李泽钜再增持长和(00001.HK)及长实集团(01113.HK)
长和系发言人回应指,一间由李嘉诚及李泽钜各自拥有50%权益之公司,於4月1日、4月2日、4月3日及4月6日,分别以平均42.3881元、42.7875元、42.986元及43.45元购入长实集团(01113.HK)共195.9万股。
同时另一间由李嘉诚及李泽钜各自拥有50%权益之公司亦於4月3日以平均价每股52.0514元购入长和(00001.HK)共10.15万股。
完成後,李嘉诚於长实集团持股由34.43%增至34.48%;李泽钜持股由34.5%升至34.55%。长和方面,李嘉诚持股由30.13%升至30.14%;李泽钜由30.204%升至30.206%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.